HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Stephan Richter Selected Research
Stephan Richter Research Topics
Disease
8
Sarcoma (Soft Tissue Sarcoma)
01/2022 - 01/2013
5
Neoplasms (Cancer)
01/2022 - 01/2018
3
Multiple Sclerosis
09/2021 - 05/2019
3
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2004 - 01/2004
2
Relapsing-Remitting Multiple Sclerosis
01/2022 - 01/2021
1
Acute Kidney Injury (Acute Renal Failure)
01/2022
1
Margins of Excision
01/2022
1
Ulcerative Colitis
01/2022
1
Hemangiosarcoma (Angiosarcoma)
03/2021
1
Liver Failure
03/2021
1
Neutropenia
10/2020
1
Febrile Neutropenia
10/2020
1
Testicular Neoplasms (Testicular Cancer)
02/2020
1
Pain (Aches)
01/2020
1
Anorexia
01/2020
1
Cachexia
01/2020
1
Autoimmune Diseases (Autoimmune Disease)
05/2019
1
Type 1 Diabetes Mellitus (Autoimmune Diabetes)
05/2019
1
Chordoma
01/2019
1
Alveolar Rhabdomyosarcoma
01/2018
1
Cardiovascular Diseases (Cardiovascular Disease)
01/2017
1
Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve)
12/2016
1
Cardiotoxicity
01/2016
1
Heart Failure
01/2016
1
Leiomyosarcoma
01/2014
1
Myocardial Infarction
01/2013
Drug/Important Bio-Agent (IBA)
4
Pharmaceutical Preparations
IBA
01/2022 - 01/2016
3
pazopanib
FDA Link
01/2022 - 10/2020
2
Alemtuzumab (Campath)
FDA Link
01/2021 - 05/2019
2
Trabectedin
IBA
01/2020 - 01/2013
2
Anthracyclines
IBA
01/2016 - 01/2013
2
Proteins (Proteins, Gene)
FDA Link
06/2004 - 01/2004
1
Methotrexate (Mexate)
FDA Link
Generic
01/2022
1
Sphingosine-1-Phosphate Receptors
IBA
01/2022
1
glucarpidase
IBA
01/2022
1
tyrosine receptor (receptor, tyrosine)
IBA
01/2022
1
ozanimod
IBA
01/2022
1
Cladribine
FDA Link
Generic
09/2021
1
Tablets
IBA
09/2021
1
Paclitaxel (Taxol)
FDA Link
Generic
03/2021
1
Monoclonal Antibodies
IBA
01/2021
1
Membrane Glycoproteins (Membrane Glycoprotein)
IBA
01/2021
1
Doxorubicin (Adriamycin)
FDA Link
Generic
10/2020
1
cabazitaxel
FDA Link
02/2020
1
4-amino-4'-hydroxylaminodiphenylsulfone (HADS)
IBA
01/2020
1
olaparib
IBA
01/2019
1
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
01/2019
1
Poly(ADP-ribose) Polymerase Inhibitors
IBA
01/2019
1
Anaplastic Lymphoma Kinase
IBA
01/2018
1
Tyrosine Kinase Inhibitors
IBA
01/2018
1
Crizotinib
IBA
01/2018
1
Fingolimod Hydrochloride (FTY720)
FDA Link
01/2017
1
Dexrazoxane (Zinecard)
FDA Link
Generic
01/2016
1
Gemcitabine
FDA Link
01/2014
1
Docetaxel (Taxotere)
FDA Link
01/2014
1
X-Linked Inhibitor of Apoptosis Protein
IBA
06/2004
1
Survivin
IBA
06/2004
1
Apoptosis Regulatory Proteins
IBA
03/2004
1
Inhibitor of Apoptosis Proteins
IBA
01/2004
Therapy/Procedure
9
Therapeutics
01/2022 - 03/2004
2
Palliative Care (Palliative Therapy)
01/2020 - 01/2017
1
Aftercare (After-Treatment)
01/2022
1
Radiotherapy
01/2022
1
Neoadjuvant Therapy
01/2013
1
Drug Therapy (Chemotherapy)
06/2004